scispace - formally typeset
F

Federico Lavorini

Researcher at University of Florence

Publications -  162
Citations -  5182

Federico Lavorini is an academic researcher from University of Florence. The author has contributed to research in topics: Inhaler & Medicine. The author has an hindex of 33, co-authored 137 publications receiving 3953 citations. Previous affiliations of Federico Lavorini include UniFi.

Papers
More filters
Journal ArticleDOI

Coughing in Laryngectomized Patients

TL;DR: The results suggest that the lack of signals arising from the larynx may result in a reduction of cough volume acceleration as well as in the intensity of abdominal muscle contractions during RCT, which may contribute to the onset and/or the persistence of chest infections in laryngectomized patients.
Journal ArticleDOI

Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab.

TL;DR: In this article, the effect of tocilizumab administration was evaluated in a subset of patients with SARS-CoV-2 infection and the results showed that the treatment resulted in at least partial reversion of the metabolic alterations due to SARS infection.
Journal ArticleDOI

Addressing the Impact and Unmet Needs of Nonadherence in Asthma and Chronic Obstructive Pulmonary Disease: Where Do We Go From Here?

TL;DR: It is concluded that a combined effort from payers, health care professionals, and manufacturers could make a real difference to asthma and chronic obstructive pulmonary disease control, as well as to health care budgets.
Journal ArticleDOI

Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes

TL;DR: The working principles of DPIs are described and their key properties are summarised in order to help prescribing the correct inhaler for each patient.
Journal ArticleDOI

Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat® or HandiHaler®

TL;DR: In this paper, the authors reviewed HandiHaler and Respimat(® Soft Mist™ Inhalers from a patient perspective and discussed factors that influence device preference and treatment compliance and reviews tools that can aid health care professionals to better match inhaler devices to individual patients' needs.